Intellectual Property India Publishes Patent Application for 'Substituted 3-Fluorobenzenepropanoate Compound, Preparation Method Therefor, Pharmaceutical Compositions, And Uses' Filed by Tianjin Gudui Bio-Pharm Co. Ltd.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517037615 A) filed by Tianjin Gudui Bio-Pharm Co. Ltd., Tianjin, China, on April 18, for 'substituted 3-fluorobenzenepropanoate compound, preparation method therefor, pharmaceutical compositions, and uses.'

Inventor(s) include Gao, Qingzhi; Liu, Shengnan; Sun, Ziru; Liu, Yang; Du, Jinping; Han, Jianbin; Li, Yang; Zhang, Shunjie; Zhao, Fuping; and Gao, Xiangqian.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "A substituted 3-fluorobenzenepropanoate compound represented by formula (I), an optical isomer thereof, a pharmaceutically acceptable salt thereof, a solvate (such as a hydrate) thereof, a clathrate thereof, a racemate thereof, a co-crystal thereof, an isotopic label thereof, or a nitrogen oxide thereof, as well as pharmaceutical compositions and uses thereof. The compound has significantly elevated drug activity, and can effectively treat and/or prevent inflammation, pain, fever, cancer, or senile dementia."

The patent application was internationally filed on Oct. 07, 2023, under International application No.PCT/CN2023/123222.

Disclaimer: Curated by HT Syndication.